Including yesterday's news, Malaysia had secured 54.8M doses, which is for 27.4M population. But the list did not include Cansino vaccines.

So where does this leave Solution/Cansino?

Solution is SEA distributor. Solution will do the F&F. Malaysia has 33M population, only 25M vaccine users and will share among 5 brands. But SEA has 655M population.

The suspension of Sinopharm's vaccine trial in Peru already been lifted.

https://www.straitstimes.com/world/peru-says-chinas-sinopharm-may-resume-coronavirus-vaccine-trial-after-volunteers-illness

Rest assured, if anything wrong with the China vaccines or government, western media will be the 1st to report it, and they they will make it sound like the end of the world!

If you can't find the news in Google, it is 100% fake. If you can, it's still 50:50.

bowman... https://www.globaltimes.cn/content/1209389.shtml

this is just a piece of news, same as the China Press. But seriously, how do you think the US will miss this news if it's true?

Of cos there will be no middle man because you will buy directly from the licensed distributors in the region.

The ChinaPress news is fake news. If it is half true, the western medias would have make it sound like end of the world! Anyway, it's sad to know the fake news was generated by Taiwan medias.

Coronavirus mutates, hence we need to jab yearly. Otherwise, why people jabs flu vaccines yearly?

Unless Pharma invest into the cold chain, otherwise we won't be able to see the -70C vaccines in our shore. This investment is not going to give any good ROI to any logistic company. In addition, it is not a global vaccines when certain groups are unable to take it.

UAE says Sinopharm vaccine has 86% efficacy against COVID-19

https://www.reuters.com/article/health-coronavirus-emirates/uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19-idUSKBN28J0G4

Sinovac is with Biofarma Indonesia.

"2. Wuhan Institute of Biological Products / Sinopharm, and

3. Beijing Institute of Biological Products / Sinopharm

No, you didn’t read wrong. The two points above are because one company has two vaccine candidates undergoing trials at two different facilities.

The state-owned China National Pharmaceutical Group Co, Ltd (Sinopharm) is conducting Phase III clinical tests for two vaccine candidates developed by Wuhan Institute of Biological Products and Beijing Institute of Biological Products respectively, with testing involving two dosages given 21 days apart.

On November 17, GI Healthcare Resources Sdn Bhd, which is partnering Sinopharm, said the vaccine candidates are undergoing Phase 3 clinical trials involving more than 55,000 individuals in 10 countries including the UAE, Bahrain, Egypt, Morocco.

The Malaysian company also noted that the emergency use of the two vaccine candidates have been approved in China, the UAE and Bahrain for over one million frontliners.

GI Healthcare also proposed to sponsor 10,000 of Sinopharm’s vaccines — which can be stored between 2 to 8 degrees Celsius — for emergency use in Malaysia by frontliners."

Still GI Healthcare...Hmmm...

https://www.malaymail.com/news/malaysia/2020/12/09/the-13-covid-19-vaccines-in-the-final-stages-of-testing-to-be-used-in-malay/1930142

Does anyone know any info of this E-MO Biology Inc.? Can't seem to find anything on google.

There is no H***L until the sticker supplier says so.

Only Vaccines that are developed using mNRA technologies need -70C. Any other non mNRA only need less than -10C.

Dear Brutus121,

You are right, Shoe companies will definitely know their production rate. However, if an Oil Company which has an Oil Producing Asset does not know their production rate, then there is a big problem.

Unless you are telling me you have no interest in knowing the numbers, then it is perfectly understandable that my questions are irrelevant. Otherwise, please don't bash me for asking if any smart and informative investor can help answer.

Thanks.

I'm one of the tiny shareholders of Hibiscus. I have some questions. And I know there are a lot of smart and informative investors in this forum. If you are seeing this, please kindly help answer. Thanks in advance.

1) Anasuria is their sole revenue generator?

2) What is their production quantity per month, quarter, and year?

3) What is the quantity per sale?

4) How many sales per quarter and year are we expecting for July 2016 to Jun 2017?

5) Assuming their average selling price is at USD40/bbl, how much is the revenue per quarter and year?

6) What is their expecting GP and NP per quarter and year?

7) What was the number of sales and average price for the last fiscal year in order for them to get the revenue as per reported?

8) Will they generate more revenues for year ending 30th June 2017 in comparison with 2016?

9) If the answer to question 8 is YES, are we going to see a first positive P&L?

10) How can a first positive P&L going to affect the stock price?

If the rumor is true, anything below 1.50 is consider cheap

AA rumors or privatization at 1.50 - 1.65 range

BUY on Rumors, SELL on Facts

Rumors - Fed was not going to hike rates

Facts - Fed did not hike rates

BUY on Rumors, SELL on Facts.

If the Facts are as the Rumors, the upside or downside usually won't last for more than 3 trading days.

If it's vice versa, it usually has an immediate effect.

Cheers!